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The herpes simplex virus DNA polymerase is composed of two subunits, a large catalytic subunit (Pol) and
a smaller subunit (UL42) that increases the processivity of the holoenzyme. The interaction between the two
polypeptides is of interest both for the mechanism by which it enables the enzyme to synthesize long stretches
of DNA processively and as a possible target for the rational design of novel antiviral drugs. Here, we
demonstrate through a combination of insertion and deletion mutagenesis that the carboxy-terminal 35 amino
acids of Pol are crucial for binding UL42. The functional importance of the interaction was confirmed by the
finding that apol mutant defective for UL42 binding retained polymerase activity, but did not synthesize longer
DNA products in the presence of UL42. Moreover, several association-incompetent mutants failed to
complement the replication of a pol null mutant in a transient transfection assay, confirming that the Pol-UL42
interaction is necessary for virus replication in vivo and therefore a valid target for directed drug design.
Replicative DNA polymerases generally function as mul-
tiprotein complexes, including a catalytic subunit and one or
more accessory proteins that modify the properties of the
core polypeptide. The mechanism by which such proteins
interact to form an enzyme capable of replicating long
stretches ofDNA rapidly and processively is of considerable
interest. In part because of the ease with which the viral
genetic information can be modified, the herpes simplex
virus type 1 (HSV-1) DNA polymerase provides an excellent
model system for the study of the structure and function of
polymerase complex association. The HSV catalytic subunit
(Pol) also shares considerable sequence homology with a
large family of eukaryotic and prokaryotic DNA poly-
merases, including the major eukaryotic replicative enzymes
(16, 20, 44), suggesting a broad conservation of functional
mechanisms, possibly extending to those depending on less
well-conserved accessory subunits.
Herpes simplex virus is also a significant pathogen, caus-
ing considerable morbidity and some mortality. To date, the
most successful anti-HSV drugs have been directed against
catalytic sites of the polymerase (reviewed in reference 4),
but especially in immunocompromised patients, resistance
to the commonly used compounds is a growing problem (19).
Therefore, the identification of alternative therapeutic tar-
gets is of interest, and as previously hypothesized, the
interaction between Pol and its accessory subunit may well
provide such a distinct target (10).
Pol normally associates with the 65-kDa double-stranded-
DNA-binding protein encoded by the UL42 gene (14, 37, 42).
One known function of UL42 is to increase the ability of Pol
to synthesize longer DNA products (16, 18) through an
increase in processivity (16). Both pol and UL42 are essen-
tial genes for viral growth (1, 22, 27, 29, 38), leading to the
hypothesis that the interaction between the two polypeptides
is also essential (10, 16).
* Corresponding author.
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Previously, we succeeded in reconstituting the Pol-UL42
complex in vitro by the translation in rabbit reticulocyte
lysate of bacteriophage RNA polymerase-generated tran-
scripts coding for the two proteins and demonstrated that
UL42 bound to the carboxy-terminal 228 amino acids of Pol,
a region of previously unknown function (10). Here, we
present the results of experiments designed to define more
clearly the nature of the Pol-UL42 interaction, through
finer-scale mapping of the Pol residues involved in UL42
binding and analysis of the ability of these mutants to
synthesize long DNA products in the presence of UL42. We
also test the hypothesis that the Pol-UL42 interaction is
necessary for viral growth by examining the ability of
mutants deficient in UL42 binding to support replication in
virus-infected cells.
MATERIALS AND METHODS
Linker insertion mutagenesis. A plasmid containing a full-
length copy of the pol gene (pDP2A [28]) was pseudoran-
domly linearized by digestion with the 4-bp recognition
sequence restriction enzyme HaeIII (New England Biolabs)
or 7haI (Bethesda Research Laboratories). The digests were
done in the presence of an empirically determined concen-
tration of ethidium bromide sufficient to inhibit further
digestion of linear plasmid molecules generated by the first
endonuclease cut (36). The digested plasmid was then linker
tailed by ligation in the presence of an excess of the
unphosphorylated 12-bp palindromic oligonucleotide, TG
CATCGATGCA, generating predominantly linear DNA
molecules containing a copy of the linker at both ends. To
facilitate mapping of the insertion site, the 12-bp oligonucle-
otide used was designed to contain a ClaI restriction endo-
nuclease site, a sequence not found in the pol gene. The
linker was also designed so as not to contain either termina-
tion or proline codons in any of the three possible reading
frames. High-molecular-weight DNA was separated from
noncovalently bound oligonucleotide, by centrifugation
through a Centricon-100 filter (Amicon) in the presence of
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10% dimethyl sulfoxide (25). Linear unit-length plasmid was
gel purified from a 1% low-melting-point agarose gel, al-
lowed to reanneal, and transformed into Escherichia coli
DH5a (Bethesda Research Laboratories). Colonies were
screened for intact plasmids containing a single insertion
within the gene of interest by standard minipreparation and
restriction enzyme digest procedures. Mutants were desig-
nated according to the codon position disrupted by the
insertion or, for in-frame insertions, the codon immediately
5'. One mutant, designated F-1208, contained a linker inser-
tion at codon 1208 from which the final base pair of the linker
had been deleted. This resulted in the expression of a
polypeptide in which the final 28 amino acids had been
replaced by an unrelated sequence of 30 residues, thus
maintaining the approximate size of the polypeptide, but not
the primary structure. For in vitro expression and immuno-
precipitation analysis, the central 2,350-bp BglII-PstI frag-
ment of the pol gene was removed from these plasmids and
replaced with a BglII-PstI fragment from pT730AN960 (see
next section) containing a bacteriophage T7 RNA poly-
merase promoter upstream of amino acid codon 960 of the
pol gene. The resulting plasmids could be transcribed in vitro
to produce mRNA encoding the carboxy-terminal 276 amino
acids of Pol plus the desired insertion. In some cases, a
900-bp PstI-XbaI fragment encoding the C terminus of the
mutant Pol was excised from the pDP2A or the pT730
construct and ligated into similarly cut p911. p911 contains
the entire pol gene cloned into pBluescript KSII+ (Strata-
gene) under the control of a bacteriophage T3 promoter. The
insertion mutant I-1216 was generated by linearizing plasmid
pT730AN960 (see below) with the enzyme NaeI and then
linker tailing as described above. The precise locations of
insertion mutants that could not be unambiguously located
by restriction mapping were determined by dideoxy nucle-
otide sequencing, as were those of insertions that altered
UL42 binding.
Deletion and nonsense mutagenesis of pol. Plasmid
pT730AN960, encoding the final 276 amino acids of Pol
under the control of a bacteriophage T7 promoter, was
constructed by using an FspI site at nucleotide 3458 of the
pol gene (15) and a downstream EcoRV site in the polylinker
of plasmid pING30 (10) to excise a 1.1-kb DNA fragment,
which was then ligated into the SmaI site of plasmid pT7-7
(40). In this construct, an in-frame ATG codon is supplied by
the vector. Amino-terminal deletions are numbered accord-
ing to the first residue of the full-length protein present.
Plasmid pT730AN1075 was constructed in a similar fashion,
except that an RsaI site at nucleotide 3791 of the pol gene
was used. Plasmids pT730AN960(A1060-1078), -(A1078-
1115), -(A1115-1131), -(A1131-1175), and -(A1175-1203), en-
coding the indicated deletions in the background of AN960,
were constructed by using the ClaI sites in the correspond-
ing linker insertion mutants (therefore, these constructs also
encode a four-amino-acid insertion from the linker). Briefly,
the pT730/N960 family of constructs was digested with PstI
and ClaI to divide the plasmid into a vector fragment
containing the T7 promoter and pol sequences 3' to the
insertion, and a small fragment containingpol sequences 5'
to the insertion, but downstream of the PstI site. These DNA
fragments were then purified by agarose gel electrophoresis
and religated in the appropriate combinations to generate the
internal deletions. Mutants AN960AC1207 and AN960AC
1216 (numbered according to the final Pol-specific residue
present) were generated by linearizing plasmids pT730A
N960(I-1208) and -(1-1216), respectively, with ClaI before in
vitro transcription to generate mRNAs lacking pol-specific
coding capacity downstream of the numbered amino acid.
The corresponding truncations of the full-length Pol
polypeptide, n-1207 and n-1216, were constructed by linear-
izing the appropriate pT330 construct with ClaI and then
linker tailing with the partially self-complementary oligonu-
cleotide CGCTAGTCTAGACTAG as described above. The
linker contains stop codons in all three translational reading
frames and an XbaI restriction enzyme site. The four mu-
tants described above also contain additional non-Pol-spe-
cific amino acids at their C termini arising from the linkers;
in single-letter code, n-1207 contains an additional VHR
sequence; n-1216, CIASLD; AC1207, VH; AC1216, CI.
In vitro transcription, translation, and immunoprecipita-
tion. Plasmids were transcribed in vitro after linearization
with the appropriate restriction enzyme, and the resulting
mRNA was translated in rabbit reticulocyte lysate as previ-
ously described (10). Mutant Pol proteins were tested for
their ability to bind cotranslated UL42 by immunoprecipita-
tion with antisera specific to either polypeptide. Briefly,
mRNAs encoding mutant Pol proteins or UL42 were trans-
lated either singly to provide controls for the specificity of
the immunoprecipitation reactions, or together to allow the
polypeptides to associate. Aliquots of the in vitro transla-
tions were then analyzed by gel electrophoresis before and
after immunoprecipitation with antisera directed against
either polymerase or UL42, as previously described (10),
except that siliconized microcentrifuge tubes (National Sci-
entific Supply Co.) were used to reduce the background of
nonspecific precipitation, and antiserum 13809 (32; gener-
ously provided by H. Marsden) was used to precipitate
UL42.
Transient complementation of a pol null mutant. Vero cells
at approximately 80% confluence were transfected with 300
ng of the indicated pDP2A or pT330 plasmid by the DEAE-
dextran method. Sixteen hours later, the cells were infected
with the HSV DNA Pol null mutant HP66 at a multiplicity of
infection of 3. HP66 has a 2.2-kb deletion of the pol gene
replaced by a lacZ gene (29). After virus adsorption for 1.5 h,
the cells were washed twice with serum-free medium before
and after treatment for 2 min with an acid-glycine-saline
wash (3) to remove extracellular virus, before the addition of
fresh medium. Twenty-four hours later, virus was harvested
(5) and titers were determined on the DP6 cell line, which
contains a resident copy of the pol gene and is therefore
permissive for HP66 growth (29). Titers of progeny were also
determined on Vero cells to ensure that they did not arise
from recombination events. Under the conditions used, 300
ng of DNA was saturating for transfection efficiency, there-
fore minimizing the effect of small errors in DNA quantita-
tion.
Overexpression and purification of Pol and UL42. Both
polypeptides were purified from lysates of Sf9 cells infected
with recombinant baculoviruses containing either the pol
(BP58 [28]) or UL42 (AcNPV/UL42, generously supplied by
J. Gottlieb and M. Challberg [16]) gene. Protein was purified
essentially by published methods (16, 29), but with modifi-
cations for Pol that will be reported elsewhere (43).
Polymerase activity assays. Polymerase assays were done
by a modification of the protocol reported in reference 15.
Briefly, 5 ,ul of reticulocyte lysate or, in some reactions, 15
fmol of purified Pol was diluted in 50 ,ul of buffer containing
100 mM (NH4)2SO4, 20 mM Tris-Cl (pH 7.5), 3 mM MgCl2,
0.1 mM EDTA, 0.5 mM dithiothreitol, 4% glycerol, 40 ,ug of
bovine serum albumin per ml, 60 p,M dATP, dGTP, and
dTTP, 10 p.M [a-32P]dCTP (2 ,uCi), and 50 fmol of a singly
primed M13 or ~X174 single-stranded template prepared as
VOL. 67, 1993
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FIG. 1. Deletion analysis of the ULA2-binding domain. The
indicated Pol mutants were synthesized in rabbit reticulocyte lysate
containing [35S]methionine both without (-) and with (+) UL42
mRNA and then analyzed by gel electrophoresis before (lanes T)
and after immunoprecipitation with anti-Pol sera (lanes 1) or anti-
UL42 sera (lanes 2). Arrowheads indicate the migration of UL42 and
the Pol mutants (APol).
described below. For certain reactions, 80 fmol of purified
UL42 was added. Incubation was at 37°C for 30 min. The
reactions were then terminated by the addition of an equal
volume of 1% sodium dodecyl sulfate (SDS)-10 mM
EDTA-10 mM Tris-Cl (pH 8)-200 ,ug of proteinase K per ml.
After incubation at 37°C for 1 h, the samples were ethanol
precipitated and then resuspended in 50 ,ul of 50 mM
NaOH-2.5 mM EDTA-25% glycerol-0.025% bromocresol
green and fractionated on a 1.3% alkaline agarose gel by
standard procedures (26).
Singly primed M13 template was prepared by hybridizing
25 ,ug of M13mp18 positive-strand DNA (Pharmacia) with a
twofold molar excess of M13 single-strand primer (Pharma-
cia) in 500 ,ul of 100mM NaCl-50 mM Tris-Cl (pH 7.6)-i mM
EDTA. The reaction mixture was heated to 90°C for 5 min
and then cooled slowly to room temperature. Excess primer
was removed by filtration through a Centricon-100 spin-filter
(Amicon) according to the manufacturer's instructions.
Primed OX174 DNA (New England Biolabs) was prepared
by the same procedure except that the oligonucleotide
5'-GGCGCATAACGATACCACTGACC was used as a
primer.
RESULTS
Deletion mutagenesis ofpol to refine the N-terminal bound-
ary of the UL42-binding domain. Previously, the carboxy-
terminal 228 amino acids (AN1008) of Pol had been shown to
be sufficient to bind UIA2, although with lower efficiency
than the intact protein (10). Therefore, initially we tested the
ability of both slightly larger and smaller carboxy-terminal
(C-terminal) Pol fragments to bind ULA2 when expressed in
rabbit reticulocyte lysate. Figure 1 shows the results ob-
tained with polypeptides containing the final 276 and 161
amino acids of Pol (AN960 and AN1075, respectively). In
Fig. 1A, it can be seen that both UL42 and AN960 were
immunoprecipitated by antiserum directed against either
protein when cotranslated, but were only precipitated by the
cognate serum when translated independently (Fig. 1A,
AN960, and C, UL42). As previously demonstrated, this
specific coprecipitation provides evidence of a stable inter-
action between the two polypeptides. In Fig. 1B, it can be
seen that although both UL42 and AN1075 were precipitated
by anti-Pol serum when cotranslated, the converse did not
TABLE 1. Locations and altered sequences of Pol C-terminal
insertion mutations
pol mutanta Sequencechangeb
1-1012.. A-VHRCT
1-1060 A-VHRCT
I-1078.. A-*VHRCT
1-1088 A-VHRCT
1-1091.. A-VHRCT
1-1115 A-VHRCT
I-1131.. A-VHRCT
1-1175 A-VHRCT
1-1203.. A-VHRCT
1-1208 A-VHRCT
1-1216.. CIDA
a The insertion mutants are numbered according to the number of the amino
acid codon disrupted by the linker insertion, except for the in-frame insertion
1-1216, which is numbered according to the codon immediately 5' to the
insertion.
b The inserted amino acid sequences are given in standard single-letter
code. Also indicated where appropriate is the identity of the wild-type codon
destroyed by the insertion.
seem to be true, in that the Pol polypeptide was not
coprecipitated by anti-UL42 serum when UL42 was present.
Nevertheless, the consistent one-sided cross-precipitation of
the polypeptides does indicate an interaction, although most
probably a less stable one than that observed between UL42
and larger Pol fragments.
Linker insertion mutagenesis of UL42-binding domain. The
above experiments suggested that AN960 would provide a
suitable background for testing the effect of the linker
insertion mutations on ULA2 binding, as this fragment of Pol
bound UL42 in vitro with an apparently equal efficiency to
the full-length protein (8), but unlike full-length protein, it
contained a number of methionine residues similar to UL42,
so providing an approximately equal autoradiographic in-
tensity when labelling with [3 S]methionine. Therefore, 10
linker insertion mutations and 1 frameshift mutation which
had been mapped to the C terminus of the pol gene were
subcloned into plasmid pT730AN960 and then tested for
their ability to bind UL42 as described above. The locations
and identities of the inserted amino acids are described in
Table 1. Figure 2 shows the results obtained with five of the
mutants, in which it can be seen that three of the altered
polypeptides, containing insertions at amino acids 1115,
1131, and 1175, respectively, behaved like the "wild-type"
AN960, in that both UL42 and the mutant Pol protein could
be immunoprecipitated by either antiserum when cotrans-
lated. However, a four-amino-acid insertion at amino acid
1216 (I-1216) severely impaired this interaction, as only
slightly larger than background quantities of UL42 and the
mutant Pol were cross-precipitated by the heterologous
antisera (Fig. 2D). In addition, a frameshift mutation,
F-1208, which replaced the final 27 amino acids of Pol with
an unrelated sequence of approximately the same length,
displayed even less ability to associate detectably with UL42
in the immunoprecipitation assay (Fig. 2E).
Of the 1 frameshift and 11 insertion mutants examined,
eight bound UL42 indistinguishably from wild-type Pol,
while the others either did not detectably bind ULA2 (I-1208
and F-1208) or did so at significantly reduced levels (1-1203
and 1-1216). Figure 3 summarizes the locations of these
mutations and the effect they had on complex formation. The
three insertions and one frameshift affecting UIA2 binding
were all located at the very C terminus of the protein, while
J. VIROL.
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FIG. 2. Linker insertion mutagenesis of the UL42-binding domain. The indicated Pol mutants were expressed in reticulocyte lysate and
analyzed for their ability to bind UL42 as described in the text and the legend to Fig. 1.
the eight insertions upstream of these had no discernible
effect. Therefore, the extreme C terminus of the polypeptide
is critical for the Pol-ULA2 interaction.
Internal deletion and nonsense mutagenesis of the UL42-
binding domain. Fortuitously, all but the most C terminal of
the insertions were in the same reading frame (Table 1) and
could therefore be used to create a series of small in-frame
deletions spanning the C terminus of Pol. Such deletions
would help delineate amino acid residues not necessary for
ULA2 binding and could potentially indicate whether the
disruptive effect of the three C-terminal insertions was direct
or indirect. Accordingly, a set of deletions was created that
1-1012
V
IG&VLVDAHRaITDPzRDIQD7VLTARHPRrnTN1c RLAVTY1M 1059
1-1060 1-1078 1-1088 1-1091
V V VV
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1-l11151- 3
V V
ALPSPAXRPRETPSHADPPG 1.LV3ELAEDPAXAIAHGVALUTD 1159
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FIG. 3. Summary of the locations and effect of various Pol linker
insertion and deletion mutants on UILA2 binding. The C-terminal
sequence of the HSV DNA polymerase (strain KOS) is shown from
amino acid 1010 onward, and the locations of insertions (triangles)
and deletions (bars) are shown. Open shapes indicate mutations with
little or no effect on UL42 binding, filled shapes indicate mutations
that severely affected UL42 binding, and cross-hatched areas cor-
respond to mutations that had an intermediate phenotype. Shaded
boxes outline a heptad hydrophobic repeat. See text for discussion.
removed most residues between amino acids 1060 and 1235
of Pol in steps ranging in size from 17 to 45 amino acids, in
the background of the large amino-terminal deletion AN960.
The mutant polypeptides were then tested for their ability to
bind UL42 as described above.
Figure 4 shows the results obtained with four such dele-
tions located between amino acids 1059 and 1204. The two
more amino-terminal deletions A1060-1078 (Fig. 4A) and
A1078-1115 (Fig. 4B) still coprecipitated with anti-UL42 in
amounts not significantly different from the parental
polypeptide AN960. However, a more C-terminal deletion,
A1131-1175 (Fig. 4C), indirectly precipitated UL42 with
anti-Pol antisera at wild-type levels, but was coprecipitated
by anti-UL42 sera in lower amounts, suggesting that it was
altered but not totally deficient in binding activity for UL42.
Similarly, the next deletion, A1175-1203, was also impaired
in its ability to bind UL42, but still evidenced an interaction
with ULA2, as it was reproducibly precipitated by anti-UL42
serum in the presence of UL42, although it did not always
reciprocally coprecipitate UL42 with anti-Pol sera (Fig. 4D).
However, two C-terminal truncations created by linearizing
the plasmid template at the ClaI site of the linker in I-1208
and I-1216 (AC1207 and A1216, respectively) totally failed to
bind UL42 (Fig. 4E, and data not shown).
We also tested the effect of the disruptive C-terminal
mutations on UL42 binding when set in the background of
full-length polymerase, because although AN960 bound
UL42 with an efficiency similar to that of the wild-type
protein, it was possible that deletion of the amino terminus
of the protein increased the apparent severity of the C-ter-
minal mutations. In addition, we wished to assay for the
effect of these mutations on polymerase function in vitro and
in transfected Vero cells, which required the background of
full-length Pol (see below). Therefore, we subcloned the 3'
end of the mutant pol genes into a plasmid containing the
entire HSV Pol gene under the control of a bacteriophage T3
promoter (pT330 series), to allow the expression of full-
length Pol proteins containing the desired mutation by in
vitro transcription and translation as described above (8).
Mutants equivalent to AC1207 and AC1216 (n-1207 and
n-1216, respectively) were created by linearizing the appro-
priate insertion mutant with ClaI and then linker tailing with
an oligonucleotide containing stop codons in all three read-
ing frames as described in the Materials and Methods. When
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FIG. 4. Internal deletion analysis of the UL42-binding domain. The indicated Pol deletions were tested for their UIA2-binding ability as
described in the text and the legend to Fig. 1. Panels D and E are taken from higher-percentage gels than panels A to C.
tested, the mutations displayed phenotypes similar to those
seen when set in the background of AN960, in that I-1208,
1-1216, F-1208, n-1207, and n-1216 showed very little UL42-
binding ability, while I-1203 was less impaired, but clearly
reduced from wild-type levels (8).
The effects and locations of the complete set of deletions
are summarized in Fig. 3, where it can be seen that like the
insertion mutants, the more carboxy-terminal mutations had
the greatest effect. The very large amino-terminal deletion
AN1075 retained some UL42-binding function, while Pol
mutants lacking amino acids between 1059 and 1116 bound
UL42 at apparently wild-type levels. Deletions further
downstream had a progressively greater impact on complex
formation, culminating in C-terminal truncations as short as
19 amino acids which totally failed to bind UL42. These
results also show that the C terminus of Pol is crucial for
binding UL42.
DNA polymerase activity on singly primed M13 templates.
To attempt to correlate UL42 binding with polymerase
function, we next tested selected mutant Pol proteins for
both intrinsic DNA polymerase activity and polymerase
activity in the presence of UL42. Previous work has shown
that Pol alone synthesizes relatively short products on a
singly primed single-strand DNA template when at a low
polymerase-to-template ratio, but will synthesize much
longer products in the presence of ULA2, and that this can be
taken as an indication of the processivity of the enzyme (16,
18). Therefore, based on a previous observation that in
vitro-translated Pol is enzymatically active (12), the mutant
Pol polypeptides were expressed in rabbit reticulocyte lysate
and then tested for DNA polymerase activity in the presence
or absence of UL42 on a uniquely primed single-strand
circular DNA template. Newly synthesized single-strand
DNA was monitored by autoradiography after fractionation
on an alkaline agarose gel. Figure 5 shows the results
obtained with wild-type Pol, either purified from an overex-
pression system or expressed in reticulocyte lysate, and the
mutants I-1131 and F-1208. Both purified Pol and the reticu-
locyte lysate expressing wild-type Pol synthesized predom-
inantly short-length DNA of around 100 to 300 nucleotides in
the absence of UL42 (lanes 1 and 5), but synthesized
significantly longer products, including a small amount of
full-length M13, when 80 fmol of purified UL42 was added to
the reactions (Fig. 5, lanes 2 and 6). Therefore, the assay
displays a clear distinction between the size of DNA prod-
ucts synthesized by Pol with and without UL42. Consistent
with its apparently wild-type behavior in the heterodimer-
ization assay, the Pol mutant containing an insertion at
4?
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FIG. 5. DNA polymerase activity of Pol mutants containing
lesions in the UIA2-binding domain. Purified Pol (lanes 1 and 2), or
reticulocyte lysate programmed with water (lanes 3 and 4), or
mRNAs encoding the indicated Pol proteins (lanes 5 to 10) were
tested for polymerase activity on a singly primed M13 single-
stranded DNA template in either the presence (+) or absence (-) of
80 fmol of purified ULA2. Newly synthesized single-stranded DNA
was monitored by autoradiography after fractionation on an 1.3%
alkaline agarose gel. The migration of full-length M13 is indicated.
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TABLE 2. Ability of selected Pol mutants to complement a pol
null mutant virus in a transfection assay'
Pol mutant o% Comple-mentationb
1-1060 ............................................. 0.67
I-1078 ............................................. 17
1-1088 ............................................. 72
1-1091 ............................................. 71
I-1115 ............................................. 81
I-1131 ............................................. 87
1-1175 ............................................. 1.6
I-1203 ............................................. 67
I-1208 ............................................. 10
I-1216 ............................................. 98
F-1208 ............................................. 0.05
n-1207 ............................................. 0.09
n-1216 ............................................. 0.06
No plasmid............................................. 0.09
a Values are calculated as a percentage relative to the complementation
seen with the wild-type gene. All results are the average of at least three
separate experiments.
b Figures in boldface are considered to be significantly lower than wild-type
complementation.
amino acid 1131 also synthesized longer DNA products in
the presence of UL42 (Fig. 5, lanes 7 and 8). However, the
mutant F-1208 only synthesized short products irrespective
of added UL42 (Fig. 5, lanes 11 and 12), which is consistent
with its failure to bind UL42, and indicative of the impor-
tance of a functional interaction between the two proteins.
To control for possible instability of the F-1208 polypeptide,
aliquots of the Pol assays were analyzed by SDS-polyacryl-
amide gel electrophoresis after DNA synthesis had been
terminated, but no degradation of the expressed polypeptide
was detected (8).
Transient complementation of a pol null mutant. The hy-
pothesis that the Pol-UL42 interaction is necessary for viral
replication predicts that mutants deficient in UL42 binding
should also be impaired for growth. Therefore, we examined
the effects of some of the pol mutations described above in
virus-infected cells by testing their ability to complement the
replication of a virus lacking an intactpol gene. Accordingly,
Vero cells were transfected with plasmids containing the
full-length mutant pol genes and superinfected with a defec-
tive virus containing a deletedpol gene (HP66 [29]), and the
titers of the resulting progeny were determined on a cell line
permissive for growth of the defective virus. HP66 cannot
replicate without an exogenously supplied Pol (29), so any
resultant progeny in this assay resulted from functional Pol
supplied in trans by the transfected plasmids. The results
obtained with 10 insertion mutants and 3 of the deletion
mutants are presented in Table 2. In general, the data are
consistent with the in vitro analysis of ULA2 interaction. The
majority of the linker insertion mutants which had no ob-
servable defect in UL42 binding also significantly comple-
mented the growth of HP66. Conversely, the insertion
mutation at amino acid 1208 failed to complement replication
of the defective virus to wild-type levels, which is consistent
with its greatly reduced ability to bind UL42. Similarly, both
of the small C-terminal truncations, n-1207 and n-1216, and
the frameshift mutant F-1208 failed to complement the pol
null mutant. This is also consistent with the inability of
F-1208 to synthesize longer DNA products in the presence of
UL42 (Fig. 5). In addition, immunofluorescence experiments
showed that both n-1207 and F-1208 were expressed and
localized to the nucleus (8), indicating that their replication
incompetence was not attributable to instability or incorrect
cellular localization. Therefore, these data support the hy-
pothesis that the Pol-UL42 interaction is necessary for viral
replication. However, the insertion mutants I-1203 and
I-1216, which were at least partially defective in interacting
with UL42, did complement viral growth, while two inser-
tion mutants, at positions 1059 and 1175, with no apparent
defect in heterodimer formation failed to complement HP66.
These results will be discussed below.
DISCUSSION
The C-terminal 35 amino acids of Pol are critical for UL42
binding. Previously, we had shown that UL42 stably bound
to the C-terminal 228 amino acids of the HSV DNA poly-
merase (10). Here, we present experiments that further
delineate the residues of Pol involved in association with
UL42. The analysis of 11 separate four-amino-acid inser-
tions within this region suggested that the area downstream
of amino acid 1203 was especially crucial for UL42 binding.
In confirmation of this, individual small deletions of all but
the C-terminal 35 amino acids of Pol were tolerated without
totally abolishing complex formation. Sequences upstream
of these 35 amino acids clearly play a role in UL42 binding,
as indicated by the lessened coprecipitation efficiencies
shown by AN1075 and A1114-1132, for example. However,
as upstream sequences seem insensitive to insertion muta-
genesis and display no residual binding activity in the
absence of the extreme C terminus, we suggest they are
involved indirectly, possibly inducing the correct folding or
presentation of the actual protein-protein contact area. In
contrast to the relatively small effect of the more-upstream
deletions, the loss of as few as 19 amino acids from the C
terminus totally abolished the ability to bind UIA2.
The interpretation of results obtained with the C-termi-
nally truncated mutants is complicated by their construction
from insertion mutants which were themselves defective for
UL42 binding. However, we note that while I-1216, AC1216,
and n-1216 were all impaired for UL42 binding in the
coimmunoprecipitation assay, AC1216 appeared more defec-
tive for ULA2 binding than the parental I-1216, and similarly,
n-1216 was clearly more severely affected than I-1216 as it
failed to complement replication of apol null mutant. There-
fore, the overall results suggest that UL42 binds to the
extreme C terminus of Pol, with the last 35 or so amino acids
strongly implicated as containing the actual site of interac-
tion.
Possible structures for the C terminus of Pol. The Robson-
Gamier secondary structure prediction algorithm predicted a
predominantly alpha-helical structure for the final 35 amino
acids of Pol (Fig. 6A), interrupted by a poorly predicted
region centered on four glycine residues (residues 1210 to
1217). In addition, the last 35 amino acids also contain a
heptad hydrophobic repeat (shaded in Fig. 3), composed of
three leucines and two alanines. Residues at the i + 3
position are also largely hydrophobic, which, taken with the
secondary structure prediction, is suggestive of an amphi-
pathic helix. Figure 6B shows the amino acid sequence
plotted out on a helix-wheel diagram, where it can be seen
that one face of the putative helix is mainly hydrophobic,
while the other face contains several polar and charged
residues. Also indicated are five potential helix-stabilizing
salt bridges between oppositely charged residues in i, i + 3,
or i + 4 positions (24, 30). Therefore, it is possible Pol and
UL42 associate through a coiled-coil hydrophobic interac-
tion, similar to that observed in fibrous proteins such as
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FIG. 6. Structural predictions for the Pol C terminus. (A) Robson-Garnier secondary structure prediction for the C-terminal 75 amino acids
of Pol. Values were calculated over a 17-residue span. Arrows indicate the positions of the three insertion mutants which affected UL42
binding. Symbols: El, helix; *, sheet; *, turn; O, coil. (B) Helical wheel representation of residues 1203 to 1235 of Pol. The view is from the
NH2 terminus, with the axis of the helix running into the page. The first two helical turns are boxed, with shaded boxes representing
predominantly hydrophobic positions, and hatched boxes positions that contain one or more charged residues. Dashed lines indicate potential
helix-stabilizing salt bridges.
myosin (6), or more recently in the leucine zipper class of
DNA-binding proteins (24, 34, 35). One prediction of such a
hypothesis is that a corresponding amphipathic helix must be
present in UL42, and indeed, a region of predicted alpha-
helix with a 3-4 hydrophobic repeat exists between amino
acids 239 and 256 of the protein. Alternatively, the postu-
lated amphipathic helix on Pol may bind to a hydrophobic
patch or pocket on UL42, as proposed for the interaction
between calmodulin and a variety of peptide and protein
ligands (33). A third possibility of a kinked alpha-helix,
perhaps involved in a conformational change upon binding
UL42, is raised by the four glycine residues between two
well-predicted helices. In this respect, it is interesting that
the HSV-2 Pol contains a proline residue within the region
containing the glycine residues (41). At an extreme, the two
helices could form a hairpin structure with each other
stabilized by a hydrophobic interface, as proposed for the C
terminus of bacteriophage T4 gene 32 protein (2). This would
suggest that the interaction with ULA2 itself might be hydro-
philic, based on the exterior surface of the amphipathic
helix. Further mutagenesis of Pol and UL42 should be able
to test these possibilities (9).
Implications for development of antiviral drugs. Despite the
efficacy of a variety of nucleoside analog-based antiviral
drugs, most notably acyclovir, there is growing interest in
the possibility of rationally designed inhibitors aimed at
blocking or interfering with protein-protein interactions.
Such a strategy is generally initiated with peptides designed
to mimic an interface involved in the association of the target
polypeptides. Examples of this approach include peptide-
based inhibitors of the two-subunit HSV ribonucleotide
reductase (7, 13), the M-NP association in influenza virus
(45), and the Oct-1-VP16 complex of HSV (17). If a partic-
ular protein complex is to provide a suitable target for this
sort of intervention, the interaction must perform an essen-
tial function. With the HSV Pol-UL42 interaction, both
polypeptides have previously been shown to be required for
viral growth, and UIA2 had been shown to alter the catalytic
properties of Pol, so it seemed likely that formation of the
heterodimer was essential. Here, we present experiments
which strongly support this hypothesis. While several Pol
C-terminal insertion mutants with little or no defect in UL42
binding could also complement apol null mutant in trans to
close to wild-type levels, the four mutants most severely
impaired for UIA2 binding did not (I-1208, F-1208, n-1207,
and n-1216). We also demonstrated that the mutant F-1208
retained polymerase activity in vitro, but could not synthe-
size longer DNA products in the presence of ULA2. In
addition, the failure of F-1208 to complement replication of
the pol-deficient virus was unlikely to have resulted from
instability or incorrect intracellular localization of the pro-
tein, as immunofluorescence experiments revealed nuclear
staining (8). Therefore, as the only demonstrated defect in
F-1208 is its failure to interact correctly with UL42, it is
likely that this accounts for its inviability in vivo. This lends
credence to the hypothesis that the Pol-ULA2 interface is a
valid target for the design of novel therapeutic agents. In
support of this, preliminary experiments have shown that
peptides corresponding to the C terminus of Pol inhibit
processive synthesis by the holoenzyme (11), and similarly,
UL42-based peptides also inhibit DNA synthesis (31).
In general, the ability of the mutants to bind UL42 in the
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immunoprecipitation assay correlated well with their pheno-
type in the in vivo complementation assay. However, two of
the insertion mutants, I-1203 and I-1216, significantly com-
plemented replication of a pol null mutant despite an obvi-
ously decreased ability to bind UL42 in vitro. These mutants
also synthesized some longer DNA products in the presence
of UL42 on a primed single-stranded DNA template (8). We
feel that this apparent contradiction in phenotype most likely
reflects the degree of impairment seen and the relatively high
stringency of the immunoprecipitation assay. Although im-
paired, 1-1203, and to a lesser extent I-1216, retained some
ability to form a complex with ULA2, while during the
immunoprecipitation assay, the association between the two
polypeptides has to be of sufficient avidity to survive the
presence of antibody, detergents, and a low overall protein
concentration. In fact, some components of the bacterio-
phage T4 DNA replication complex have been shown to
associate stably only in the presence of a high macromolec-
ular concentration (21).
Is UL42 binding sufficient to confer processivity? Interest-
ingly, two of the insertion mutants (I-1060 and 1-1175) failed
to complement replication of the poI-defective virus even
though they bound UL42 in vitro at apparently wild-type
levels. This may result simply from instability of the mutant
proteins in vivo or from defects in Pol function not assayed
for in this study. However, although the experiments pre-
sented here provide evidence that the Pol-UL42 association
is essential for polymerase function in vitro and in vivo, they
do not directly address whether merely binding UL42 is
sufficient to increase the processivity of the enzyme. That
UL42 binds to double-stranded DNA suggests the attractive
hypothesis that it increases the processivity of Pol by
clamping it to the primer template (16) in a manner analogous
to but mechanistically distinct from that of the 1-subunit of
Escherichia coli Pol III (the 1-subunit has no intrinsic affinity
for DNA [23, 39]). Nevertheless, it is possible that UL42
also induces an alteration in how Pol itself contacts DNA (or
Pol induces an alteration in UL42) which contributes to the
processivity of the enzyme, and that simple addition of the
UL42 DNA-binding activity is not sufficient. The recent
finding that the C terminus of Pol contains a DNA-binding
site (43) provides a functional basis for this proposal.
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